JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2015, Vol. 29 ›› Issue (2): 81-85.doi: 10.6040/j.issn.1673-3770.0.2014.362

Previous Articles     Next Articles

Murine model of ocular toxoplasmosis and feature of fundus

LI Zhi-wei, ZHANG Han   

  1. Department of Ophthalmology, Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Received:2014-11-14 Online:2015-04-16 Published:2015-04-16
  • Contact: 张晗。E-mail:13705310696@139.com E-mail:13705310696@139.com

Abstract: Objective To establish murine model for ocular toxoplasmosis and observe the fundus and pathological changes. Methods 20 BALB/C mice were randomly divided into the control and experimental group with 10 mice per group. In the experimental group, mice were fed orally with toxoplasma type Ⅱ PRU strains cyst. Changes of fundus were observed daily and fundus photography were taken after 1 month, 2 months and 3 months, respectively. After 3 months, serum IgG of the mice was detected by ELISA assays. The mice were sacrificed and the eyes were harvested. Pathological damages of retina and choroid tissue were observed after HE staining. Results After two weeks, fundus inflammation was noticed in the experimental group, including optic disc edema, retinal angioplerosis, edema and hemorrhage along with retinal vascular, from the beginning of the optic disc area gradually expanded to the surrounding blood vessels. These changes aggravated with time. Significant titers change in serum IgG, significant higher than the control group (P<0.001), from the retinal and choroid tissue slice of the experimental group mice, we could see the retinal and choroid apparent edema, the gap between the organization was loose, lacuna was formed,inflammatory cell infiltration was found in tissue of retinal and choroid. Conclusion Infecting mice with type Ⅱ toxoplasma PRU strains via oral route could be a good way to establish animal model for ocular toxoplasmosis, which can cause inflammation of the choroid and retina.

Key words: Fundus change, Inflammation, Pathological observation, Ocular toxoplasmosis

CLC Number: 

  • R774
[1] 赵慰先.人体寄生虫学[M].北京:人民卫生出版社, 1994:257-267.
[2] Park Y H, Nam H W. Clinical features and treatment of ocular toxoplasmosis[J]. Korean J Parasitol, 2013, 51(4):393-399.
[3] Holland G N. Ocular toxoplasmosis: a global reassessment. Part I: Epidemiology and course of disease[J]. Am J Ophthalmol, 2003, 136(6):973-988.
[4] Subauste C S, Ajzenberg D, Kijlstra A. Review of the series‘Disease of the year 2011: toxoplasmosis’pathophysiology of toxoplasmosis[J]. Ocul Immunol Inflamm, 2011, 19(5):297-306.
[5] Tenter A M, Heckeroth A R, Weiss L M. Toxoplasma gondii: from animals to humans[J]. Int J Parasitol, 2000, 30(12-13):1217-1258.
[6] Garweg J G. Determinants of immunodiagnostic success in human ocular toxoplasmosis[J]. Parasite Immunol, 2005, 27(3):61-68.
[7] Tugal-Tutkun I, Corum I, Otük B, et al. Active ocular toxoplasmosis in Turkish patients: a report on 109 cases[J]. Int Ophthalmol, 2005, 26(6): 221-228.
[8] Lahmar I, Guinard M, Sauer A, et al. Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis[J]. Exp Parasitol, 2010, 124(2):190-196.
[9] Perkins E S. Ocular toxoplasmosis[J]. Br J Ophthalmol, 1973, 57(1):1-17.
[10] Tedesco R C, Vitor R W, Brando G P, et al. Ocular toxoplasmosis signs in mice embryo[J]. Micron, 2007, 38(7):729-733.
[11] Sauer A, Lahmar I, Scholler M, et al. Development of murine models of ocular toxoplasmosis andpreliminary results of ocular inflammatory transcriptome[J]. J Fr Ophtalmol, 2009, 32(10):742-749.
[1] XIN Min, WANG Shaoming. Neuroimmune mechanisms and therapeutic strategies of inflammatory and infectious olfactory dysfunction [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 111-124.
[2] MIAO Hongli, ZHANG Yanchun, HAO Linna, TANG Le, HE Yingnan. Clinical features and prognostic analysis of active ocular toxoplasmosis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 82-89.
[3] LI Lilin, LI Xinyi, GUAN Jian. Research progress on the mechanism of comorbidity between obstructive sleep apnea and depression [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 89-96.
[4] YE Qiang, LUOSONG Bazong, NAN Suting, WANG Hao, MA Jinhai, LYU Peng, ZHANG Wenfang. Research progress on pigment epithelial derived factor and dry eye [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 151-156.
[5] LUN Yingjun, CHEN Chen, GAO Hongcheng, FAN Qinglin, TAI Renqing. Role of Toll-like receptor 4/nuclear transcription factor-κB channels in diabetic retinopathy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 163-168.
[6] ZHU Han, LIU Xuexia, ZHANG Hua. Study on the role of autophagy in the pathogenesis of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 79-86.
[7] YUAN Yuqi, CAO Zine, NIU Xiaoxin, XIE Yushan, SU Yonglong, ZHU Simin, ZHANG Yitong, LIU Haiqin, REN Xiaoyong, SHI Yewen. Clinical significance of peripheral blood inflammatory markers in obstructive sleep apnea hypopnea syndrome with hypertension [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 85-92.
[8] CUI Ning, WANG Yunmeng, YANG Jingpu. Research progress on the role and regulatory mechanism of group 2 innate lymphoid cells in chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 153-159.
[9] WANG Weiyi, SHI Lei, ZHANG Zhiyu, ZHANG Guiling, SHI Guanggang. Effects of high fat diet on allergic rhinitis mice and intestinal flora [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 21-29.
[10] LI Cong, LI Ling, LIU Tingyan, CHEN Liang. Research progress on influencing factors of aminoglycoside antibiotic ototoxicity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 128-134.
[11] ZHANG YuOverview,QU YiGuidance. Research progress on the pathogenesis and control of ocular toxoplasmosis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 70-76.
[12] AO Tian,CHENG Lei. An endotype study of chronic rhinosinusitis with nasal polyps and precise control and treatment under the guidance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 7-14.
[13] SHI Shuai, ZHENG Quan,CHENG Lei. Research advances of dupilumab in the treatment of chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 36-42.
[14] HUANG Danyi, ZHANG Ting,CHEN Jing, ZHANG Wei. Progress of research regarding the role of the epithelial barrier in chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 78-83.
[15] WANG Na,CHAI Xiangbin. Research progress on prostate-derived ETS factor in asthma and inflammatory diseases of the nasal mucosa [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 136-141.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!